| CSTONE PHARMAC. DL-,0001 |
| China |
| Gesundheit |
| KYG2588M1006 / A2PEFW |
| PH4 (Frankfurt) |
| FRA:PH4, ETR:PH4, PH4:GR |
| - |
| http://www.cstonepharma.c.. |
|
CStone Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative oncology therapies. It primarily focuses on developing groundbreaking treatments for cancer, addressing a range of unme..
>Volltext.. |
| 954.18 Mio. EUR |
| 886.42 Mio. EUR |
| 32.36 Mio. EUR |
| -44.22 Mio. EUR |
| -52.03 Mio. EUR |
| -0.04 EUR |
| 44.34 Mio. EUR |
| 92.36 Mio. EUR |
| -39.52 Mio. EUR |
| 1.8 |
| -33.37% |
| -377.81% |
| - |
| - |
| - |
| - |
| CSTONE |
| 28.08.26 |
|
||||
|